BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26641246)

  • 21. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.
    Buteau H; Pezet A; Ferrag F; Perrot-Applanat M; Kelly PA; Edery M
    Mol Endocrinol; 1998 Apr; 12(4):544-55. PubMed ID: 9544990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
    Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural and molecular history of prolactinoma: insights from a
    Bernard V; Villa C; Auguste A; Lamothe S; Guillou A; Martin A; Caburet S; Young J; Veitia RA; Binart N
    Oncotarget; 2018 Jan; 9(5):6144-6155. PubMed ID: 29464061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the
    Vroonen L; Beckers A; Camby S; Cuny T; Beckers P; Jaffrain-Rea ML; Cogne M; Naves L; Ferriere A; Romanet P; Elenkova A; Karhu A; Brue T; Barlier A; Pétrossians P; Daly AF
    Front Endocrinol (Lausanne); 2023; 14():1242588. PubMed ID: 37711900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
    Hao W; Skarulis MC; Simonds WF; Weinstein LS; Agarwal SK; Mateo C; James-Newton L; Hobbs GR; Gibril F; Jensen RT; Marx SJ
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3776-84. PubMed ID: 15292304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel somatic mutation of POU6F2 by whole-genome sequencing in prolactinoma.
    Miao Y; Li C; Guo J; Wang H; Gong L; Xie W; Zhang Y
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1022. PubMed ID: 31692290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant Prolactin Receptor in Agalactia and Hyperprolactinemia.
    Kobayashi T; Usui H; Tanaka H; Shozu M
    N Engl J Med; 2018 Dec; 379(23):2230-2236. PubMed ID: 30575453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
    Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
    Lim JH; Kim TY; Kim WH; Park JW
    Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medullary thyroid carcinoma arises in the absence of prolactin signaling.
    Kedzia C; Lacroix L; Ameur N; Ragot T; Kelly PA; Caillou B; Binart N
    Cancer Res; 2005 Sep; 65(18):8497-503. PubMed ID: 16166330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma Risk.
    Chakhtoura Z; Laki F; Bernadet M; Cherifi I; Chiche A; Pigat N; Bernichtein S; Courtillot C; Boutillon F; Bièche I; Vacher S; Tanguy ML; Bissery A; Grouthier V; Camparo P; Foretz M; Do Cruzeiro M; Pierre R; Rakotozafy F; Tichet J; Tejedor I; Guidotti JE; Sigal-Zafrani B; Goffin V; Touraine P
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4449-4460. PubMed ID: 27575941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
    Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression.
    Amaral VC; Maciel GA; Carvalho KC; Marcondes RR; Soares JM; Baracat EC
    Gen Comp Endocrinol; 2013 Aug; 189():105-10. PubMed ID: 23684968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolactin and its receptor: From animal models to pituitary pathophysiology].
    Begon E; Bernard V
    Biol Aujourdhui; 2022; 216(3-4):105-110. PubMed ID: 36744975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRLR regulates hepatic insulin sensitivity in mice via STAT5.
    Yu J; Xiao F; Zhang Q; Liu B; Guo Y; Lv Z; Xia T; Chen S; Li K; Du Y; Guo F
    Diabetes; 2013 Sep; 62(9):3103-13. PubMed ID: 23775766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.